Axsome Therapeutics Hosts R&D Day Today with Key Opinion Leaders Focusing on AXS-05 and Unmet Needs in Depression, Alzheimer’s Disease Agitation, and Nicotine Dependence

Ads

You May Also Like

Adamas Announces Data Presentation on ADS-5102 at the Academy of Managed Care Pharmacy 2017 Annual Meeting

EMERYVILLE, Calif., March 28, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced ...

$9.36 Bn Nuclear Medicine/Radiopharmaceutical Market, 2024

Dublin, Aug. 07, 2018 (GLOBE NEWSWIRE) -- The "Nuclear Medicine/Radiopharmaceutical Global Market - Forecast ...